期刊文献+

胱抑素C在评价2型糖尿病患者肾功能中的应用价值

Value of Cystatin C for the Evaluation of Renal Function of Type 2 Diabetes Mellitus
下载PDF
导出
摘要 [目的]探究血清胱抑素C(Cysc)在评价2型糖尿病(T2DM)患者肾功能中的应用价值。[方法]选取T2DM患者95例,依据尿蛋白分为无蛋白尿组(A组)40例,微量白蛋白尿组(B组)34例,临床蛋白尿组(C组)21例,使用免疫比浊法测定患者的空腹血肌酐(SCr)与血清CysC水平并计算肌酐清除率(CCr)。[结果]B、C组患者血清SCr、CysC水平均高于A组,CCr水平低于A组(P〈0.05),CCr随蛋白尿程度加重而下降。B、c组患者血清SCr、CysC水平与CCr呈负相关(P〈0.01),且B组患者中,CysC与CCr的相关性更强(P〈0.01)。[结论]血清CysC可以作为评价糖尿病肾病患者肾功能的指标,尤其适用于早期糖尿病肾病患者。 [Objective]To explore the value of cystatin C(Cys C) for assessing renal function of patients with type 2 diabetes mellitus(T2DM). [Methods] According to urinary protein, 95 T2DM patients were di- vided into non-proteinuria group(group A, n = 40), microalbuminuria group (group B, n = 34) and clinical proteinuria group(group C, n =21). Immune turbidimetry was used to measure the fasting serum creatinine (SCr) and serum Cys C. Creatinine clearance(CCr) was calculated. [Results] Serum SCr and Cys C of group B and group C were higher than those in group A, while CCr in group B and group C was lower than that in group A( P 〈0.05). CCr decreased with the severity of proteinuria. In group B and group C, serum SCr and Cys C were negatively correlated with CCr( P〈0.01). Especially in group B, the correlation between Cys C and CCr was stronger( P 〈0.01). [Conclusion]Serum Cys C can be used as indicators of the evaluation of re- nal function in patients with diabetic nephropathy, especially for patients with early diabetic nephropathy.
出处 《医学临床研究》 CAS 2014年第1期62-64,共3页 Journal of Clinical Research
关键词 糖尿病 2型 Diabetes Mellitus, Type 2 Kidney
  • 相关文献

参考文献10

  • 1陆琼,贾中伟,张敏,徐元宏.随机尿白蛋白/肌酐与血清胱抑素C在诊断糖尿病肾病中的价值[J].安徽医科大学学报,2011,46(3):273-275. 被引量:18
  • 2魏宇鹏,张季,杨金萍.血胱抑素C和尿中4种蛋白联合检测对早期糖尿病肾病的诊断价值[J].中国临床研究,2011,24(8):722-722. 被引量:13
  • 3Ayodele Odutayo. Cystatin C and acute changes in glomerular filtration rate[J]. C!in NephroZ , 2012,78 (1) : 64-75.
  • 4Reboldi G, Gentile G, Angeli F, al . Microalbuminuria and hypertension[J]. Minerva Med ,2005,96(4) 2611.
  • 5Grubb A,Simonsen O,Sturfelt G, e al. Serum concentration of eystatin C,factor D and beta 2-microglobulin as a measure of glornerular filtration rate[J]. Acta Med Scand , 1985,218 (5) :499-503.
  • 6Yun Kyung Jeonl, Mi Ra Kim, Jung Eun Huh, et al . Cysta- tin C as an early biomarker of nephropathy in patients with type 2 diabetes[J]. J Korean Med Sci ,2011,26(2) :258-263.
  • 7Suzuki Y, Matsushita K, Seimiya M, et al . Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes[J]. Clin Chem Lab Med ,2012,50(10) :1833-839.
  • 8Bevc S, Hojs R, Ekart R, et al . Simple eystatin C formula for estimation of glomerular filtration rate in overweight pa- tients with diabetes mellitus type 2 and chronic kidney disease [J]. Erp Diabetes Res ,2012:179849. Epub 2012 Sep 12.
  • 9Dhia RB, Hellara I, Harzallah O, et al . Evaluation of the re- nal function in type 2 diabetes: ciearartce calculation or cysta- tin C[J]. Ann Biol Clin (Paris) ,2012,70(3):287-294.
  • 10Dharnidharka VR, Kwon G, St evens G. Serun cystain C is superior to serum creatinine as a marker o[ kidney funetion:a meta analysis[J]. Am J Kidney Dis ,2002,40(2):221-226.

二级参考文献8

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部